Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

An introduction to CPHI Spain

19th November 2026

On 1-2 June 2027, Fira Barcelona in Montjuïc will host the newest show in the international pharma calendar: CPHI Spain. The event will provide a launchpad for the Spanish pharma industry to build meaningful connections and partnerships, across the country and beyond. With all attendees sharing an active business interest in the region, the scale and setting of the show is tailored to offer all visitors the insights they need to make their mark on the country’s pharmaceutical sector. 

What is CPHI Spain? 

CPHI Spain is a brand new show designed to establish Spain as a key destination on the pharmaceutical map. With more 35+ years of experience in connecting the industry, CPHI will be bringing their experience with the full pharma supply chain to Barcelona, facilitating two days of connection, innovation and international pharmaceutical expertise. The show will see Montjuïc’s Fira Barcelona welcome 2500+ attendees and 130+ exhibitors over two days, helping pharma companies of all sizes find a foothold in the Spanish pharma market. 

Operating on a more in-depth scale than the annual flagship CPHI Global show, the event offers the international pharma community a chance to have the in-depth discussions that drive real progress. As with all CPHI events, CPHI Spain will also provide an in-depth content programme, which will offer professional expertise in regulation and policy, as well as pricing and industry trends. There will also be range of unique networking activities and experiences, using the sights of this spectacular city as a backdrop. 

In the long-term, the aim of CPHI Spain is to boost the country’s status in the pharma ecosystem, bringing tangible benefits to local and international businesses alike. For those global organisations looking to strengthen their position in the Spanish market, the event will give them access to major companies who know the local industry landscape inside and out. Meanwhile, Spanish companies can not only demonstrate the best that the country’s pharma has to offer, but position themselves as market leaders in front of a dedicated global audience. 

  • April Hung, Event Manager – Business Development Manager of Events

    “We see significant potential in connecting Spain’s pharmaceutical ecosystem with the international market, helping Spanish companies expand globally while enabling international businesses to unlock opportunities in Spain. CPHI Spain is designed to create a more focused event experience, where every participant has the visibility, time and space to build meaningful business connections.”

Exploring the Spanish pharma market

With an estimated valuation of €38.01 billion, and projected to reach €61 billion by 2033, Spain can claim the fastest-growing regional pharmaceutical market in Europe. Beyond hosting major facilities for biotech, life sciences and R&D, the country is home to more than 1,600 pharma organisations. It’s also a significant hub for trade, exporting across Europe while primarily importing from the United States and other larger continental markets, which demonstrates its critical place in the international landscape. 

Pharmaceutical growth in the country has been driven by expansion in the generics and biotech sectors thanks to companies like Kern Pharma and Reig Jofre, allowing for a greater local manufacturing presence that has helped earn the country top ranking for clinical trials across Europe. However, this success has also created pricing pressures, including lengthy approvals timescales in those sectors. What’s more, with nearly 20 individual regional healthcare services, the country’s healthcare system can be difficult for newcomers to understand without expert assistance. 

Spain offers a thriving ecosystem for manufacturing and innovation, boasting 180+ production facilities nationwide, including 79 plants in Barcelona and 39 in Madrid. Indeed, over 80% of the country’s industry turnover is located across Madrid and Catalonia, making Fira Barcelona an iconic and ideally-located choice of venue for this inaugural edition of the show. 

Who is CPHI Spain for?

Despite being more geographically targeted than other CPHI events, CPHI Spain still caters to the full cross-section of the pharma supply chain, from finished dosage and API to contract manufacturing, machinery and packaging, among many other specialisms. The main thing connecting our attendees is their shared interest in the Spanish pharma market, whether they’re local enterprises seeking international partners or global businesses in search of a direct route to potential customers and suppliers in the country. 

This focus will also help level the playing field when it comes to the kinds of companies we’re expecting at this first event. The format of CPHI Spain will allow specialist companies and SMEs the chance to enjoy the same kind of visibility as the bigger players on the exhibitor list. With an easier point-of-entry for exhibitors, including a range of turnkey stand options, the event offers an unrivalled opportunity to grow and connect with an international audience looking to build partnerships and expand their local presence. 

Meanwhile, regardless of their role or seniority, CPHI Spain attendees will also be able to get a comprehensive understanding of where the region’s pharma industry will be going. Buyers can connect with suppliers, marketers can meet manufacturers and everyone has a chance to plan their year ahead (and beyond) as far as the Spanish pharma market is concerned. 

Don’t miss this unique chance to position your company at the forefront of Spanish pharma sector by being part of the first ever CPHI Spain show. This is your golden opportunity for serious expansion at a dedicated event where connections get made and deals get done. 

You can register your interest as an exhibitor now, with stands being available to book in the new year. Attendees will also be able to register for their pass as we get closer to 2027. We will also publish a full list of exhibitors closer to the event itself, and there will be plenty more news about the content programme and networking activities in due course. 

                                              CPHI Spain

                          FAQs

CPHI Spain is a new two-day pharma event launching 1–2 June 2027 in Montjuïc, Barcelona. The show is dedicated entirely to Spain's pharma market, the second largest in Europe, and will spotlight Spain's manufacturing strength, foster SME participation and connect local leaders with international partners hunting for Spanish market access. 

CPHI Spain will be laser focused on the Spanish market and is for businesses interested in expanding across Spain and across Europe. The event brings together 130+ exhibitors and 2,500+ professionals across the full pharma supply chain. Everyone will be there including; 

  • Contract Manufacturing 
  • Finished Dosage Forms 
  • APIs 
  • Machinery 
  • Packaging 
  • ...and so much more!

CPHI Spain is a specialist event built for serious business, where deals get done, partnerships form and expansion begins.

Local Spanish companies looking to showcase their capabilities, connect with international buyers and gain targeted visibility they might not achieve at larger global events. 

International suppliers and manufacturers seeking direct access to Spain's thriving pharma market, particularly from across Europe. 

SMEs who need a more accessible, affordable event with simplified logistics and lower costs than major international exhibitions. 

Pharma professionals serious about growth whether you're in biopharma, generics, biosimilars, clinical trials, advanced therapies or digital health innovation. 

If you're looking to trade, partner or expand in Spain, CPHI Spain is built for you. 

Laser-focused. CPHI Spain zeroes in on one market: Spain. No dilution. No distraction. Every exhibitor, every attendee, every conversation is Spain-relevant. 

This means lower travel costs, simplified logistics and competitive stand pricing. It's designed for participation, not just observation.  We don't compete on stand size, so everyone gets visibility. Whether you're a multinational or a local SME, you have the same opportunity for visibility and connection. No one gets lost in the crowd. 

SME-friendly. Unlike massive global events, CPHI Spain gives smaller businesses the spotlight they deserve for greater visibility, representation and even more focused networking opportunities. 

Country-specific content. Programming built around Spain's regulatory environment, R&D landscape, generics, APIs, biopharma and regional challenges. Get highly relevant. Information that’s immediately actionable. 

Local event, national impact. CPHI Spain complements the global CPHI platform. It's the focused, regional alternative for those who want direct Spanish market access. Join a burgeoning community of 2,500+ engaged pharma professionals. Every connection counts. 

The Spanish pharma market is one of the top 5 in Europe  

Spain's pharma sector is booming, with revenue projected to reach €35.0 billion (USD 40.6 billion) by 2026 and a 4.8% CAGR through 2030. The country hosts 500+ pharma companies and 79 manufacturing plants in Catalonia alone. Barcelona leads in biopharma, clinical trials, advanced therapies, and AI-driven innovation, while Madrid anchors APIs, biosimilars, and multinational headquarters.